Skip to main content
Market intelligence
MPLTSector not reported

MapLight Therapeutics, Inc. insider activity

In the last 90 days, 1 corporate insider purchased $148,702 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$148,702
Corporate buyers
1
Latest transaction
Aug 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 3, 2026James Woodruff LillieChief Scientific OfficerSale22,082$12.54$276,908
Jul 28, 2026Troy CoxDirectorOpen Market Purchase15,620$9.52$148,702
Jul 17, 2026Anatol KreitzerChief Discovery OfficerSale36,284$37.09$1,345,893